Effectiveness of a treatment based on melatonin in five patients with systemic sclerosis

American Journal of Therapeutics

Volumn 13, Issue 1, 2006, Pages 84-87

  Todisco, Mauro ^a,b  

^a ASL 11 (Local Health Department of National Health Service)   (Italy)

^b NONE   (Italy)

Author keywords

Endothelium; Melatonin; Systemic sclerosis

Indexed keywords

ALPHA TOCOPHEROL; CORTICOTROPIN; MELATONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DROWSINESS; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; THROMBOCYTE AGGREGATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; VITAMIN E;

EID: 31544478552     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000162012.58990.4f     Document Type: Article

References (22)

1. LeRoy EC. Pathogenesis of systemic sclerosis (scleroderma). In: Koopman WJ, ed. Arthritis and Allied Conditions, 13th ed. Baltimore: Williams & Wilkins; 1997:1481.
2. Gilliland BC. Systemic sclerosis (scleroderma). In: Braunwald E, Fauci A, Kasper D, et al, eds. Harrison's Internal Medicine, 15th ed. New York: McGraw-Hill; 2001:1937-1947.
3. Todisco M, Casaccia P, Rossi N. Severe bleeding symptoms in refractory idiopathic thrombocytopenic purpura: a case successfully treated with melatonin. Am J Ther. 2003;10:135-136.
4. Di Bella L, Bucciarelli M, Pagnoni UM, et al. Formazione di complessi fra melatonina e basi puriniche e pirimidiniche. Boll Soc It Biol Sper. 1976;52:157.
5. Di Bella L, Rossi MT, Gualano L, et al. Molecular mechanism of bone marrow thrombocytogenesis by melatonin. EPSG Newslett. 1981;suppl 3:126.
6. Di Bella L, Scalera G, Rossi MT. Melatonin: an essential factor for the treatment and recovery from leukemia and cancer. In: Birau N, Schloot W, eds. Proceedings of the International Symposium on Melatonin: 28-30 September 1980, Bremen. Bremen, 1980:161-162.
7. Le Roy EC, Black CM, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-205.
8. Merkel PA, Clements PJ, Reveille JD, et al. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from Omeract 6. J Rheumatol. 2003;30:1630-1647.
9. Valentini G. Therapy of systemic sclerosis. Reumatismo. 2004;56:1-8.
10. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789-793.
11. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167-178.
12. Merkel PA, Herlyn K, Martin RW, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 2002;46:2410-2420.
13. Furst DE, Clements PJ, Steen VD, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25:84-88.
14. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-1285.
15. Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29:255-273.
16. Di Bella L, Gualano L, Rossi MT, et al. Effetti dell'azione simultanea della melatonina e dell'ADP sui megacariociti in vitro. Boll Soc It Biol Sper. 1979;55:389-393.
17. Lemaitre BJ, Launay JM, Dreux C, et al. Melatonin content, uptake and synthesis by blood platelets. EPSG 2nd Colloquim, Giesse, 1981:42.
18. Di Bella L, Rossi MT, Scalera G. Perspectives in pineal function. In: Ariens Kappers J, Pévet P, eds. The Pineal Gland in Vertebrates Including Man (Progress in Brain Research, Vol. 52). Amsterdam: Elsevier North-Holland Biomedical Press; 1979:475-478.
19. Di Bella L, Rossi MT, Scalera G, et al. Platelet turnover as influenced by melatonin. In: Birau N, Schloot W, eds. Proceedings of the International Symposium on Melatonin: 28-30 September 1980, Bremen. Bremen; 1980:117.
20. Rossi MT, Di Bella L, Gualano L, et al. Il sistema megacariociti- piastrine, organo bersaglio della melatonina. Boll Soc It Biol Sper 1981;57:25-26.
21. Rossi MT, Di Bella L. Melatonin in thrombocytogenesis. In: Gupta D, Attanasio A, Reiter RJ, eds. The Pineal Gland and Cancer. Tubingen: Brain Research Promotion; 1988:183-194.
22. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765-3777.